- Home
- AEON vs CABR Comparison
AEON vs CABR Comparison
Compare AEON & CABR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$1.16
N/A
Current Price
$0.86
Company Overview
Basic Information| Metric | AEON | CABR |
|---|---|---|
| Founded | N/A | 2020 |
| Country | United States | United States |
| Employees | 5 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Package Goods/Cosmetics |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.8M | 12.1M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | AEON | CABR |
|---|---|---|
| Price | $1.16 | $0.86 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $7.20 | N/A |
| AVG Volume (30 Days) | ★ 79.9K | 52.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.38 | $0.71 |
| 52 Week High | $1.45 | $1.65 |
Technical Indicators
Market Signals| Indicator | AEON | CABR |
|---|---|---|
| Relative Strength Index (RSI) | 50.63 | 47.33 |
| Support Level | $0.69 | $0.78 |
| Resistance Level | $1.42 | $1.08 |
| Average True Range (ATR) | 0.10 | 0.13 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 36.97 | 33.71 |
Price Performance
Historical Comparison AEON
CABR
About AEON AEON Biopharma Inc.
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.
About CABR Caring Brands Inc.
Caring Brands Inc is a consumer wellness company that supports health and wellness through research and development. Its product pipeline addresses a range of conditions, including hair loss, eczema, burns, and sexual wellness. The majority of revenue is generated from the sale of OTC and consumer products, as well as licensing royalties.